Ochre Bio’s Post

One week ago today, I had the privilege of participating in a panel presentation at the World Orphan Drug Congress USA alongside Ben Willis from Egetis Therapeutics US and Effie Parks, mother, caregiver, member of the CTNNB1 Foundation, and host of the #OnceUponaGene podcast. If you weren't able to join, here are the highlights: >Exome and genome sequencing can shorten the diagnostic odyssey for patients...by years. This is what GeneDx does best. >GeneDx's E. Gay Grossman is leading the charge to provide educational materials that teach patients and their families to have conversations with their doctors and insurance providers so they can access the testing they deserve. >GeneDx has amassed a clinical and genomic dataset that is unsurpassed by other labs and contains rich insights for pharmaceutical companies, who have taken on the noble challenge to develop therapeutics for patients with rare, ultra-rare, and nano-rare disease. Thank you Anny Bedard and Nigel Nicholls at Egetis! >GeneDx is here to stay because patients and their families need us. If you want to learn more about the panel discussion or how GeneDx can help accelerate drug discovery, send me a message! #RareDisease #Genetic Testing #Exome #Genome

The #DeciBio reports team has been busy, with three reports / updates published in the first three months of the year! Our library of syndicated market reports continues to expand, with multiple new titles expected throughout 2024. Check out our website to purchase or find more information about any of these reports: https://lnkd.in/giXc4Jrs Fill out this form to add yourself to the notification list for any of our upcoming reports: https://bit.ly/3INkyHK. Shoot me a message if you're interested in subscribing to our entire report / content library. We’d also love to hear of any ideas for report topics that you’d like to see us publish on in the future - let us know in the comments! #precisionmedicine #spatialbiology #liquidbiopsy #biomarkers #diagnostics #digitalpathology #singlecell #genomics #proteomics #cellomics #oncology #celltherapy #research #pharma #drugdiscovery #clinicalresearch #ADCs #marketresearch

We wrapped up an excellent review meeting coupled with some energizing team-building activities to kick off the new financial year. Excited about collaborating with #scientists and #clinicians worldwide! #ClinicalNGS Illumina #NGS #Sequencing #ExomeSequencing #PrecisionMedicine #Pharmacogenomics #HiFiSequencing PacBio #NGSPanels #Genotyping #SNPArray #PopulationGenomics

We have come a long way from the early days of genome sequencing and FDA first guidance on performing genomic sequencing or variant analysis of patients during clinical trials and determine the reason for why some patients are responders and other non-responders. While there was initial reluctance, the pharma companies started to profile the patients and the field of biomarkers-driven trials was born. Pharma companies soon realized that biomarker guided clinical trials resulted in faster enrollment and quicker approval. It was a win for all…FDA, Pharma and Patients. The success of targeted therapies vindicated FDA’s foresight. #PrecisionMedicine #TargetedTherapies #CancerTreatment #ClinicalTrials #LiquidBiopsy #NGS #GenomicProfiling #Trancriptomic # Comprehensive Genomic Profiling # Diagnostics # Companion Diagnostics # MRD # FDA # Biomarkers # SNPs # Variant Analysis

😎Spot on... San Diego! ten23 health is participating at the upcoming PEPTalk, this coming January 16th. Andrei Hutanu , Senior Scientist at ten23 health, is speaking at the event with following topic: 👉🏾Characterization of Adeno-Associated Viruses—Strengths and Weaknesses👈🏾 Here's what it is about: rAAVs have grown from a proof-of-concept approach into a highly promising DNA delivery vector for the treatment of monogenic disorders during the past decades. Yet, the use of these vectors is not without hurdles when it comes to meet a biopharmaceutical`s high quality standard. This talk aims to shed some light on the current status of the analytical characterization panel and to show some pain points that need to be addressed in the future. Find more information about the conference here: https://lnkd.in/eG9ZfEfu Cambridge Healthtech Institute #ten23health #peptalk #cdmo #pharma #conference #event #biopharmaceuticals #celltherapy #advancedtherapies #cellandgenetherapies #cell #gene #dna #pharmaceuticalmanufacturing #medicine #drugproduct

#FOG2024 is here! I can't wait to discuss with many top KOLs about the future of #PredictiveGenomics. Pass by booth 36 for the latest on #PharmacoGenomics, #PolygenicRiskScore #microarray #genotyping #PredictiveGenomics

SKC is excited to announce that we will be attending the World Orphan Drug Congress USA 2024, the most important and comprehensive event for the rare disease industry. The event will take place on April 23-25, 2024 and brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. 💬 🗨"Cell and gene therapy access and reimbursement challenges in Europe" is the title of a panel discussion, moderated by Dr Alexander Natz, Director General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs. SKC's founder and managing director, Univ.-Prof. Dr. Matthias P. Schönermark will discuss this important topic together with Jin Ding, Research Fellow, University of Sheffield, Jon Weber PhD MBA, Senior Director of Cell & Gene Therapies Access, Bayer and Sheela Upadhyaya, Life Science Advisor in Rare Diseases & Special Advisor, Fipra International ( 24 April at 4:00 pm). We look forward to connecting with you at the World Orphan Drug Congress USA 2024 and sharing our insights and expertise on rare diseases. We are the market access special forces. #OrphanDrugs #RareDiseases #CellTherapy #GeneTherapy #MarketAccess #Reimbursement

https://lnkd.in/g4P_vsKQ Nice example of studying the potential impacts of the microbiome in your preclinical development programs #drugdevelopment #Microbiome #functionalmetagenomics #metagenomics

Max just officially launched our first software product: ImmuneWatch DETECT! ImmuneWatch DETECT helps researchers from pharma, biotech and academia find the epitope specificity of their T-cell receptors (TCRs). This can be useful to them for numerous reasons ranging from monitoring therapy efficacy or using TCRs as biomarkers for diagnostic products to designing TCR-based therapeutics, or discovering new antigens related to autoimmune diseases for novel drug development. The bioinformatic tool is now available with a free licence for academic use and a fully featured premium version for industry users. We truly hope that it can help the whole community to gain more insights in their T cell responses. A big thank you to: 🫶 Our Early Access community who provided us valuable feedback in the last couple of months helping us achieve an average score of 4.3 out of 5 for ease of use. 🔍 The ImmuneWatch team for their dedication to make this happen. 🎤 Max van Houcke for his stellar demo on the #AIRRC7 conference today (The AIRR Community) Find out more: https://lnkd.in/eT7ERUxB

Molecular Diagnostics Market Size to reach USD 32.7 billion by 2029 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:https://lnkd.in/gnJ7v5qU The size of global molecular diagnostics market in terms of revenue was estimated to be worth $17.3 billion in 2024 and is poised to reach $32.7 billion by 2029, growing at a CAGR of 13.5% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Danaher Corporation Wohlfahrtsstiftung der F. Hoffmann-La Roche AG Hologic, Inc. Illumina Abbott bioMérieux Thermo Fisher Scientific QIAGEN Revvity Myriad Genetics Siemens Healthineers Becton, Dickinson and Company Grifols QuidelOrtho Agilent Technologies Diasorin Exact Sciences Genetic Signatures mdxhealth HTG Molecular Diagnostics Biocartis TBG Diagnostics Ltd Vela Diagnostics Amoy Diagnostics ELITechGroup Molbio Diagnostics Savyon Diagnostics Abacus Diagnostica is now Uniogen geneOmbio Technologies #moleculardiagnostics #moleculartesting #diagnostics #medicaldiagnostics #pathology #laboratorymedicine #invitrodiagnostics #IVD #biotechnology #healthcare #PCR #RTPCR #DNAtesting #RNAtesting #genotyping #sequencing #genomics #proteomics #microbiology #infectiousdiseases #oncology #genetics #personalizedmedicine #precisionmedicine